Methotrexate and Deafness transitory - a phase IV clinical study of FDA data
Deafness transitory is found among people who take Methotrexate, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Methotrexate and have Deafness transitory. It is created by eHealthMe based on reports of 517,446 people who have side effects when taking Methotrexate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
517,446 people reported to have side effects when taking Methotrexate.
Among them, 306 people (0.06%) have Deafness transitory.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 521,823 Methotrexate users for its effectiveness, alternative drugs and more.
What is Deafness transitory?
Deafness transitory (deafness temporary) is found to be associated with 607 drugs and 416 conditions by eHealthMe.
Number of Methotrexate and Deafness transitory reports submitted per year:
Time on Methotrexate when people have Deafness transitory *:
Gender of people who have Deafness transitory when taking Methotrexate*:
Age of people who have Deafness transitory when taking Methotrexate *:
Common drugs people take besides Methotrexate *:
Common side effects people have besides Deafness transitory *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Methotrexate and have Deafness transitory?Check whether Deafness transitory is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
How severe was Deafness transitory and when was it recovered:
Expand to all the drugs that have ingredients of methotrexate sodium:
Alternative drugs to, pros and cons of Methotrexate:
- Methotrexate (521,823 reports)
Common Methotrexate side effects:
Browse all side effects of Methotrexate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Deafness transitory treatments and more:
- Deafness transitory (1,025 reports)
COVID vaccines that are related to Deafness transitory:
- Deafness transitory in Moderna COVID Vaccine
- Deafness transitory in Pfizer BioNTech Covid Vaccine
- Deafness transitory in Johnson and Johnson Covid Vaccine
Common drugs associated with Deafness transitory:
All the drugs that are associated with Deafness transitory:
- Deafness transitory (607 drugs)
Common conditions associated with Deafness transitory:
All the conditions that are associated with Deafness transitory:
- Deafness transitory (416 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate) and Methotrexate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Memantine Hydrochloride and Renal Failure Acute - 4 seconds ago
- Oxsoralen and Zolinza drug interaction - 10 seconds ago
- Xalatan and Diabetic Foot - 16 seconds ago
- Lybrel and Birth Control - 22 seconds ago
- Duopa and Trulicity drug interaction - 28 seconds ago
- Klor-Con M20 and Cuts And Puncture Wounds - 29 seconds ago
- Valcyte and Ondansetron drug interaction - 35 seconds ago
- Mycophenolate Mofetil and Menopausal Symptoms - 44 seconds ago
- Mucinex and Cardiac Flutter - 45 seconds ago
- Tacrolimus and Hand-Foot-And-Mouth Disease - 53 seconds ago